Frank Ruffo
Net worth: 250 335 $ as of 30/03/2024
Profile
Frank Ruffo founded Vicept Therapeutics, Inc. in 2009, where he worked as Chief Financial Officer from 2009 to 2011 and Aclaris Therapeutics, Inc. in 2012, where he worked as Chief Financial Officer & Treasurer in 2022.
Mr. Ruffo also currently works at Aclaris Life Sciences, Inc., as Secretary, Treasurer & Director.
Mr. Ruffo also formerly worked at Cabot Medical Corp., as Finance Manager, CollaGenex Pharmaceuticals, Inc., as Vice President-Finance, PricewaterhouseCoopers LLP, as Auditor-Healthcare & Life Sciences Practice in 1991, Venatorx Pharmaceuticals, Inc., as Chief Financial Officer from 2011 to 2014, and BioLeap, Inc., as Chief Financial Officer from 2010 to 2013.
Mr. Ruffo received his undergraduate degree from LaSalle University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
03/04/2023 | 201,883 ( 0.28% ) | 250 335 $ | 30/03/2024 |
Frank Ruffo active positions
Companies | Position | Start |
---|
Former positions of Frank Ruffo
Companies | Position | End |
---|---|---|
ACLARIS THERAPEUTICS, INC. | Founder | 30/12/2022 |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Director of Finance/CFO | 31/10/2014 |
BioLeap, Inc.
BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Director of Finance/CFO | 31/12/2012 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Founder | 30/06/2011 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Director of Finance/CFO | - |
Training of Frank Ruffo
LaSalle University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ACLARIS THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Cabot Medical Corp.
Cabot Medical Corp. Medical SpecialtiesHealth Technology Cabot Medical Corp. designs and manufactures medical instruments. The firm offers endoscopes, light source, adapter optics, and other electrosurgical instruments. The company is headquartered in Langhorne, PA. | Health Technology |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Health Technology |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Commercial Services |
BioLeap, Inc.
BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Health Technology |
- Stock Market
- Insiders
- Frank Ruffo